First Annual Leadership Summit on CER Priorities, Methods and Policy
Building a Strategic Framework for Comparative Effectiveness Research in Oncology
In November 2010, the Center for Medical Technology and Policy (CMTP) convened the National Leadership Summit on CER Priorities, Methods, and Policy, focusing on oncology research. Oncology was selected as the focus of the 2010 inaugural National Leadership Summit on CER Priorities, Methods and Policy for compelling reasons. Cancer is a particularly challenging field for CER because new technologies are rapidly evolving, numerous new treatment regimens and targeted agents are available, and personalized medicine is becoming a reality. Because of this rapid change, there is an urgent and escalating need for better evidence to guide treatment and payment policies.
Six principles emerged from discussions at the Summit and are discussed at length in the Final Report:
- CER studies in oncology are urgently needed.
- CER should fully engage patients and the general public.
- CER requires the development of new research methods.
- Genomics and personalized medicine must be central to all CER studies in oncology.
- CER results must be translated into clinical practice
- The CER enterprise must address cost and value
Click Here (pdf) (1.32 MB) to download the 2010 National Leadership Summit on CER Priorities, Methods and Policy: Building a Strategic Framework for Comparative Effectiveness Research in Oncology Final Report.
For more information, contact CMTP.